Hem › Multipel skleros › Maryland
Kliniska studier för Multipel skleros i Maryland
17 studier för Multipel skleros söker deltagare vid platser i Maryland.
Städer i Maryland
Officiell studietext (engelska)
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1/2
Ålder 18 till 120 · Alla kön · Uppdaterad 2 okt. 2026 · NCT03109288Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
1 Month – 99 Years · Alla kön · Uppdaterad 2 okt. 2026 · NCT00794352Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Baltimore
- TG Therapeutics Investigational Trial Site, Glen Burnie
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT06433752Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 2
Ålder 18 till 120 · Alla kön · Uppdaterad 16 sep. 2026 · NCT02784210Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 till 120 · Alla kön · Uppdaterad 16 sep. 2026 · NCT00001248RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Sunstone Therapies, PC, Rockville
- Sheppard Pratt, Towson
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Baltimore Veterans Affairs Medical Center- Site Number : 8400163, Baltimore
RekryterarFas 3
Ålder 18 till 60 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07325292Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 2 till 120 · Alla kön · Uppdaterad 31 aug. 2026 · NCT01730131A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Mid Atlantic Epilepsy and Sleep Ctr, Bethesda
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 29 juli 2026 · NCT07225504Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- Johns Hopkins University, Baltimore
RekryterarFas 2
Ålder 18 till 60 · Alla kön · Uppdaterad 17 juli 2026 · NCT07497399Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
- Johns Hopkins University, Baltimore
RekryterarFas 2
Ålder 18 till 60 · Alla kön · Uppdaterad 9 juni 2026 · NCT06170970Pathological Basis of MRI Signal Changes in Multiple Sclerosis
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 till 120 · Alla kön · Uppdaterad 5 juni 2026 · NCT02659956Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1
Ålder 18 till 120 · Alla kön · Uppdaterad 5 juni 2026 · NCT05849467Genes and Environment in Multiple Sclerosis
- National Institute of Neurological Disorders and Stroke, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 14 maj 2026 · NCT01353547Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
- Johns Hopkins University, Baltimore
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 6 maj 2026 · NCT07389590A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Evidera INC., Bethesda
- Evidera, Bethesda
RekryterarObservationsstudie
Alla åldrar · Kvinnor · Uppdaterad 20 nov. 2025 · NCT05170126Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.